The Commonwealth Scientific and Industrial Research Organization in Australia reported the success of a trial of Dr Grader, an eye-screening tool that uses artificial intelligence for early diagnosis of diabetic retinopathy. The trial, which involved 187 diabetes patients, found that the technology was as effective in identifying signs and classifying the severity of the condition as a human specialist.
Australian researchers develop AI tool for diagnosing diabetic retinopathy
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.